Calcium Sedico (Granules) Instructions for Use
Marketing Authorization Holder
Sedico South Egypt Drug Industries, Co. (Egypt)
ATC Code
A12AX (Calcium preparations in combination with vitamin D and/or other drugs)
Active Substances
Colecalciferol (Rec.INN registered by WHO)
Ascorbic acid (Rec.INN registered by WHO)
Calcium carbonate (Ph.Eur. European Pharmacopoeia)
Dosage Form
| Calcium Sedico | Effervescent granules for the preparation of a solution for oral administration 180 mg+1.275 g+400 IU/1 sachet: 20 pcs. |
Dosage Form, Packaging, and Composition
| Effervescent granules for the preparation of a solution for oral administration | 1 sachet |
| Ascorbic acid | 180 mg |
| Calcium carbonate | 1.275 g, |
| Equivalent to calcium content | 500 mg |
| Colecalciferol | 400 IU (4.4 mg) |
3.9 g – sachets made of combined material (20) – cardboard packs.
Clinical-Pharmacological Group
Drug regulating calcium and phosphorus metabolism
Pharmacotherapeutic Group
Calcium-phosphorus metabolism regulator
Pharmacological Action
A combined drug that regulates calcium-phosphorus metabolism. It replenishes the deficiency of calcium, vitamin D3, and ascorbic acid in the body.
Calcium is involved in the formation of bone tissue, blood clotting, maintaining stable cardiac activity, and in the transmission of nerve impulses.
Colecalciferol regulates the metabolism of calcium and phosphate ions, enhances calcium absorption in the intestines and reabsorption in the kidneys.
Ascorbic acid is necessary for the formation of collagen and reparative processes in tissues, and plays an important role in biological oxidation and reduction processes, as well as in cellular respiration.
Indications
Osteomalacia; rickets; osteoporosis (climacteric and senile); increased need for calcium (period of intensive growth in children and adolescents, pregnancy, lactation period); hypocalcemia (in cases of increased excretion or reduced absorption, during long-term glucocorticosteroid therapy, hypoparathyroidism, renal osteodystrophy).
ICD codes
| ICD-10 code | Indication |
| E20 | Hypoparathyroidism |
| E55.0 | Active rickets |
| E58 | Dietary calcium deficiency |
| E83.5 | Disorders of calcium metabolism |
| M80.0 | Postmenopausal osteoporosis with pathological fracture |
| M80.1 | Osteoporosis with pathological fracture following oophorectomy |
| M81.0 | Postmenopausal osteoporosis |
| M81.1 | Postoophorectomy osteoporosis |
| M81.8 | Other osteoporosis (senile osteoporosis) |
| M83 | Adult osteomalacia |
| N25.0 | Renal osteodystrophy |
| O25 | Nutritional deficiencies in pregnancy |
| Z39.1 | Care and examination of lactating mother |
| ICD-11 code | Indication |
| 5A50.Z | Hypoparathyroidism, unspecified |
| 5B57.0 | Vitamin D-dependent rickets |
| 5B5K.1Z | Calcium deficiency, unspecified |
| 5C64.5 | Disorders of calcium metabolism |
| 8D40.2 | Myopathy due to nutritional deficiency |
| FB83.11 | Postmenopausal osteoporosis |
| FB83.1Z | Osteoporosis, unspecified |
| FB83.2Z | Adult osteomalacia, unspecified |
| GB61.Z | Chronic kidney disease, unspecified stage |
| JA64 | Nutritional disorders during pregnancy |
| QA48.1 | Care or examination of a nursing mother |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally once daily. Dissolve the entire contents of one sachet in a glass of water. Stir until the effervescence stops and a clear solution is obtained. Consume the prepared solution immediately.
For adults and adolescents, the standard dose is one sachet daily. Adhere strictly to the once-daily frequency. Do not exceed the recommended dosage.
Take the drug at the same time each day to maintain steady levels. Administer between meals or as directed by a physician. Monitor for signs of hypercalcemia during long-term therapy.
Consult a physician for dosage adjustments in specific patient populations or for conditions requiring prolonged use. Discontinue use and seek medical advice if adverse reactions occur.
Adverse Reactions
Possible: allergic reactions, dyspepsia.
With long-term use: hepatic insufficiency, pancreatitis.
Contraindications
Hypersensitivity to the components of the combination; hypercalcemia; hypercalciuria; nephrourolithiasis; chronic renal failure.
Use in Pregnancy and Lactation
Use is possible according to the dosing regimen.
Use in Renal Impairment
Contraindicated in chronic renal failure.
Pediatric Use
The drug is approved for use in children and adolescents under 18 years of age.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Mildronate capsules 500mg, 90pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Actovegin pills 200mg, 50pcs
Cortexin, 10mg, 5ml, 10pcs
Belosalic, lotion solution for external use spray 100ml
Cavinton Comfort, dispersible pills 10mg 90pcs
OKI, sachets 80mg 2g, 12pcs
Kagocel pills 12mg, 30pcs 